Article
Daclatasvir and Asunaprevir Combination Therapy-induced Hepatitis and Cholecystitis with Coagulation Disorder due to Hypersensitivity Reactions.
Internal medicine (Tokyo, Japan) - 1 Jan 2000
Miyashima Yuichi, Honma Yuichi, Miyagawa Koichiro, Oe Shinji, Senju Michio, Shibata Michihiko, Hiura Masaaki, Abe Shintaro, Harada Masaru
Abstract excerpt
A 70-year-old woman with chronic hepatitis C was admitted to our hospital due to liver injury, cholecystitis, and disseminated intravascular coagulation with a fever and skin rash. She had been on a combination regimen of daclatasvir and asunaprevir for 2 weeks of a 24-week regimen. Because of the symptoms, laboratory findings, results of a drug-induced lymphocyte stimulation test, and pathological findings of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
